XCath Robotics Receives FDA Breakthrough Device Designation for Endovascular Robot
Medical News||1 分钟阅读
核心洞察
XCath Robotics (搜索) has received FDA Breakthrough Device Designation for its endovascular robotic system.
The designation covers a robotic platform intended for use in endovascular procedures.
The source article provides no further detail on the device, its clinical data or the designation timeline.
XCath Robotics (搜索) has received Breakthrough Device Designation from the US Food and Drug Administration for its endovascular robot (搜索), according to Medtech Insight.
No further details on the device, the indication it targets, supporting clinical data or the timing of the designation were available in the source report.